Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
Hagens Berman announced a securities class action against Hims & Hers Health and certain executives, and is soliciting HIMS investors with substantial losses ahead of a Nov. 2, 2026 lead plaintiff deadline. The suit follows the FTC's July 29, 2026 federal complaint, joined by Utah and Los Angeles County, alleging Hims shared sensitive health data with Meta and Snap via tracking pixels and billed consumers for prescriptions before any medical consultation in violation of ROSCA.
Key figures
- Class period
- Aug. 4, 2025 - July 29, 2026
- Market cap loss
- over $970 million
- Stock decline pct
- -14.7%
- Lead plaintiff deadline
- Nov. 2, 2026
- Whistleblower reward cap
- 30 percent
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.